doi: 10.3390/su10020391 22 Gngora-CastilloE.Ibarra-LacletteE.Trejo-SaavedraD
What the research shows about GLP-1 medications: According to a study published in the New England Journal of Medicine (STEP-1 trial), participants receiving once-weekly semaglutide 2.4 mg plus lifestyle intervention experienced a mean weight loss of 14.9% from baseline over 68 weeks, compared with 2.4% for placebo plus lifestyle intervention
WOMAC scores were normalized and expressed on a scale of 0 to 100, with higher scores reflecting worse outcomes
PlexusDx recommends using a new needle for each injection and never reusing needles between doses
Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry
Contraindications and Precautions Generic Semaglutide Pen 0.25 mg / 0.5 mg should not be used in: Patients with a history of medullary thyroid carcinoma Individuals with MEN2 syndrome Patients with severe gastrointestinal disease A healthcare provider should assess patient history before initiating therapy